Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
163.79 USD
1.85%
Market Closed
Updated:
May 5, 2024
Abbvie Inc
EPS (Diluted)
|
Abbvie Inc
EPS (Diluted) Peer Comparison
Comparables:
GILD
AMGN
MRNA
VRTX
REGN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$12
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
EPS (Diluted)
-$12
|
CAGR 3-Years
-85%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$34
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
23%
|
See Also
What is Abbvie Inc's EPS (Diluted)?
EPS (Diluted)
2.7
USD
2.7
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's EPS (Diluted) amounts to 2.7 USD.
What is Abbvie Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
1%
1%
Over the last year, the EPS (Diluted) growth was -59%.
You don't have any saved screeners yet
